Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients
出版年份 2016 全文链接
标题
Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients
作者
关键词
-
出版物
OncoImmunology
Volume 5, Issue 7, Pages e1191732
出版商
Informa UK Limited
发表日期
2016-06-01
DOI
10.1080/2162402x.2016.1191732
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
- (2016) Kalijn F. Bol et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
- (2015) Alexander M M Eggermont et al. LANCET ONCOLOGY
- Neo approaches to cancer vaccines
- (2015) L. Delamarre et al. SCIENCE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients
- (2015) Kalijn F Bol et al. OncoImmunology
- Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination
- (2015) Kalijn F Bol et al. OncoImmunology
- Clinical use of dendritic cells for cancer therapy
- (2014) Sébastien Anguille et al. LANCET ONCOLOGY
- Dendritic-Cell-Based Therapeutic Cancer Vaccines
- (2013) Karolina Palucka et al. IMMUNITY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Challenges of Guarantee-Time Bias
- (2013) Anita Giobbie-Hurder et al. JOURNAL OF CLINICAL ONCOLOGY
- Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters
- (2012) Erik H. J. G. Aarntzen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell-Based Vaccination in Metastatic Melanoma
- (2012) E. H. J. G. Aarntzen et al. CANCER RESEARCH
- Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination
- (2012) E. H. J. G. Aarntzen et al. CANCER RESEARCH
- Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients
- (2012) E. H. J. G. Aarntzen et al. CLINICAL CANCER RESEARCH
- International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk?
- (2012) Friederike Erdmann et al. INTERNATIONAL JOURNAL OF CANCER
- Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment
- (2011) A. M. Lesokhin et al. CANCER RESEARCH
- Landmark Analysis at the 25-Year Landmark Point
- (2011) Urania Dafni
- Route of Administration Modulates the Induction of Dendritic Cell Vaccine-Induced Antigen-Specific T Cells in Advanced Melanoma Patients
- (2011) W. J. Lesterhuis et al. CLINICAL CANCER RESEARCH
- Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
- (2010) W. Joost Lesterhuis et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Utility of adjuvant systemic therapy in melanoma
- (2009) A. M. M. Eggermont et al. ANNALS OF ONCOLOGY
- In situ Expression of Tumor Antigens by Messenger RNA-Electroporated Dendritic Cells in Lymph Nodes of Melanoma Patients
- (2009) D. H. Schuurhuis et al. CANCER RESEARCH
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation